Home|DSIJArticleDetail

Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19
Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19

Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19

The stock gave multibagger returns of 160 per cent in just 1 year whereas BSE Sensex Index is up by 5 per cent.

DSIJ Intelligence Article rating: 3.6

The stock’s 52-week high is Rs 1,678.60 per share while its 52-week low is Rs 489.20 per share.

Rakesh Jhunjhunwala’s Multibagger Pharma Stock Reports Clinical Breakthrough in Combating Serious Illness
Rakesh Jhunjhunwala’s Multibagger Pharma Stock Reports Clinical Breakthrough in Combating Serious Illness

Rakesh Jhunjhunwala’s Multibagger Pharma Stock Reports Clinical Breakthrough in Combating Serious Illness

In the last one year, its share price has surged by 201.81 per cent

DSIJ Intelligence Article rating: 4.0

The shareholding pattern reveals that the estate of ace investor Late Rakesh Jhunjhunwala holds a 1.75 per cent stake in the company, amounting to over 28 lakh shares

Rakesh Jhunjhunwala’s portfolio multibagger pharma stock hit 20 per cent upper circuit & fresh 52-week high; Here’s why!
Rakesh Jhunjhunwala’s portfolio multibagger pharma stock hit 20 per cent upper circuit & fresh 52-week high; Here’s why!

Rakesh Jhunjhunwala’s portfolio multibagger pharma stock hit 20 per cent upper circuit & fresh 52-week high; Here’s why!

The stock gave multibagger returns of 250 per cent in just 1 year whereas BSE Sensex Index is up by 23 per cent.

DSIJ Intelligence Article rating: 4.3

The shares of the company saw a spurt in volume by more than 4.37 times on BSE.

DSIJ MINDSHARE

Mkt Commentary2-Apr, 2025

Multibaggers2-Apr, 2025

Multibaggers2-Apr, 2025

Multibaggers2-Apr, 2025

Mindshare2-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList